Log in to your Inderes Free account to see all free content on this page.
Alvotech
32.75 SEK
-6.43 %
Less than 1K followers
ALVO SDB
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
-6.43 %
+9.15 %
-31.46 %
-29.48 %
-56.91 %
-
-
-
-66.68 %
Alvotech is a biotechnology company that focuses on the development and manufacture of biosimilar medicines. The company's pipeline consists of biosimilar candidates aimed at treating autoimmune diseases, eye diseases, osteoporosis and cancer. The company offers its products to patients all over the world. Alvotech was founded in 2013 and has its headquarters in Reykjavík.
Read moreMarket cap
11.35B SEK
Turnover
2.69M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
7.5.
2026
Interim report Q1'26
20.8.
2026
Interim report Q2'26
12.11.
2026
Interim report Q3'26
All
Press releases
ShowingAll content types
Alvotech to Report Financial Results for the First Quarter of 2026
Alvotech files Annual Report with the SEC
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio